Yamauchi K

ORCID: 0000-0001-6587-2393 · 7 papers in corpus · active 1989-2026

Study types

  • other 4

Condition tags

  • endometriosis 4
  • dysmenorrhea 1
2026
Journal of gynecologic oncology ·doi:10.3802/jgo.2026.37.e24

ObjectiveThe treatment effects of lymphadenectomy in early-stage ovarian clear cell carcinoma (OCCC) reported in previous studies may have been overestimated owing to confounding factors. This study aimed to investigate the treatment effect…

other 2025
PloS one ·doi:10.1371/journal.pone.0327774

OBJECTIVES: The aim of this study was to utilize publicly available government statistics to evaluate the trends in the estimated proportion of patients with menstruation-related diseases, including dysmenorrhea and endometriosis, and the n…

2023
BMC women's health ·doi:10.1186/s12905-023-02777-3

BackgroundRecently, there has been a growing global movement concerning menstruation, a healthy and natural physiological phenomenon in women. The disadvantages caused by menstruation are "gender-based obstacles." Adolescent girls are also …

2014
Yonsei medical journal ·doi:10.3349/ymj.2014.55.6.1600

PurposeTransient receptor potential vanilloid 1 (TRPV1) is a ligand-gated nonselective cation channel, which can be activated by capsaicin and other noxious stimuli. Recently, an association between bone pain and TRPV1 has been reported. Ho…

other 1991
Nihon Sanka Fujinka Gakkai zasshi

Endometrial carcinoma in 40 women under 40 years of age (group A), was analyzed clinicopathologically in comparison with that in 126 women over 50 years of age (group B). 1. The incidence of endometrial carcinoma in women under 40 years of …

other 1990
Nihon Sanka Fujinka Gakkai zasshi

Immunohistochemical study with various monoclonal antibodies to the mononuclear cell surface antigens was carried out on the regional lymph nodes in patients with cervical cancer to assess the augmentative effect of lentinan. Zero, 2, 4, or…

other 1989
Nihon Sanka Fujinka Gakkai zasshi

The clinical and pathological findings in 23 cases of clear cell carcinoma of the ovary treated at Cancer Institute Hospital from January 1951 to September 1987 are discussed. Clear cell carcinoma accounted for 7.1% of all malignant tumors …